Literature DB >> 2308936

Transgenic mice expressing a soluble foreign H-2 class I antigen are tolerant to allogeneic fragments presented by self class I but not to the whole membrane-bound alloantigen.

B Arnold1, M Messerle, L Jatsch, G Küblbeck, U Koszinowski.   

Abstract

The properties of transmembrane and soluble transplantation antigens were compared with respect to the induction of tolerance and the selection of the T-cell repertoire. For this purpose, transgenic (H-2b x H-2d)F1 mice were constructed that carry integrated copies of a modified H-2Kk gene resulting in the secretion from various cell types including thymocytes of soluble H-2Kk molecules. Despite the presence of H-2Kk antigen, these mice were still able to generate an H-2Kk-specific T-cell response. This response was comparable to that produced by normal littermates when stimulated with cells expressing membrane H-2Kk in a mixed lymphocyte reaction. In contrast, only transgenic mice failed to generate a cytolytic T-cell response to soluble H-2Kk antigen expressed by recombinant vaccinia virus and presented by the H-2Db molecule. These data imply the presence of two populations of alloreactive cytolytic T cells. A small fraction of T cells recognizes alloantigen as antigenic peptide(s) presented by other major histocompatibility complex class I molecules and tolerance can be induced in this population by soluble alloantigen. The majority of T cells, however, require the whole cell membrane-expressed class I molecule for recognition. This population is not affected by tolerance induction to the soluble major histocompatibility complex class I molecule.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2308936      PMCID: PMC53563          DOI: 10.1073/pnas.87.5.1762

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

2.  Interferon sensitive and insensitive MHC variants of a murine thymoma differentially resistant to methotrexate-containing antibody-directed liposomes and immunotoxin.

Authors:  P Machy; B Arnold; S Aliño; L D Leserman
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

3.  Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes.

Authors:  W R Heath; M E Hurd; F R Carbone; L A Sherman
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

4.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

5.  H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide.

Authors:  J L Maryanski; P Pala; G Corradin; B R Jordan; J C Cerottini
Journal:  Nature       Date:  1986 Dec 11-17       Impact factor: 49.962

6.  Cytolytic T cells recognize the two amino-terminal domains of H-2 K antigens in tandem in influenza A infected cells.

Authors:  B Arnold; H G Burgert; U Hamann; G Hämmerling; U Kees; S Kvist
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

7.  Comparison of allogeneic and xenogeneic determinants on the H-2Kk molecule.

Authors:  S Koch; N Koch; P Robinson; G Hämmerling
Journal:  Transplantation       Date:  1983-08       Impact factor: 4.939

8.  Alloreactive cytolytic T-cell clones preferentially recognize conformational determinants on histocompatibility antigens: analysis with genetically engineered hybrid antigens.

Authors:  B Arnold; U Horstmann; W Kuon; H G Burgert; G J Hämmerling; S Kvist
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

9.  Immune responses to H-2Kd antigen expressed by recombinant vaccinia virus.

Authors:  B E Coupar; M E Andrew; D B Boyle; R V Blanden
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

10.  Physical mapping of vaccinia virus temperature-sensitive mutations.

Authors:  R Drillien; D Spehner
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

View more
  11 in total

1.  Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope.

Authors:  M Del Val; H J Schlicht; H Volkmer; M Messerle; M J Reddehase; U H Koszinowski
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations.

Authors:  J Dal Porto; T E Johansen; B Catipović; D J Parfiit; D Tuveson; U Gether; S Kozlowski; D T Fearon; J P Schneck
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

Review 3.  What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?

Authors:  Alan Belicha-Villanueva; Jennifer Blickwedehl; Sarah McEvoy; Michelle Golding; Sandra O Gollnick; Naveen Bangia
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

4.  Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3.

Authors:  M Messerle; B Bühler; G M Keil; U H Koszinowski
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

5.  Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus.

Authors:  M Rapp; M Messerle; B Bühler; M Tannheimer; G M Keil; U H Koszinowski
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

6.  A simple, specific, and highly sensitive blocking enzyme-linked immunosorbent assay for detection of antibodies to bovine herpesvirus 1.

Authors:  J A Kramps; J Magdalena; J Quak; K Weerdmeester; M J Kaashoek; M A Maris-Veldhuis; F A Rijsewijk; G Keil; J T van Oirschot
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

7.  Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness.

Authors:  J P Abastado; Y C Lone; A Casrouge; G Boulot; P Kourilsky
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

8.  Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.

Authors:  G Benichou; P A Takizawa; P T Ho; C C Killion; C A Olson; M McMillan; E E Sercarz
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

9.  T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules.

Authors:  Z Liu; Y K Sun; Y P Xi; P Harris; N Suciu-Foca
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

10.  Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.

Authors:  G Benichou; P A Takizawa; C A Olson; M McMillan; E E Sercarz
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.